ProStrakan Group Unveils Amgen Collaboration Deal, Placing To Boost Cash Pile

July 13, 2006 |

1 min read

ProStrakan Group PLC this morning unveiled a potentially lucrative collaboration deal with US biotechnology group Amgen Inc, alongside plans to raise 11.3 mln stg in a share placing to shore up its cash pile.

Alliances Europe

Amgen

MORE ON THIS TOPIC

Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties

IPO

Apnimed eyes up to $160M IPO to prep for sleep apnea drug launch

July 28, 2026

·

2 min read

·

Tristan Manalac

Winding road leads to the light of the lighthouse. Stock vector illustration

Rare diseases

Oak Hill takes SPAC track to Nasdaq with Roche asset in tow

July 28, 2026

·

2 min read

·

Tristan Manalac

Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration

FDA

UPDATE: FDA disputes Capricor’s claims of Phase 3 success for DMD cell therapy

July 27, 2026

·

3 min read

·

Heather McKenzie

3D Paper Cut Pair of Lung dotted with yellow tumor bacteria infection spread across on a blue background with no text. Yellow dots as virus infection in the lungs. Vector Illustration.

Business

Gossamer regains rights to lung disease asset from Chiesi after Phase 3 fail

July 27, 2026

·

3 min read

·

Gabrielle Masson